dcterms.isReferencedBy |
Wilhelmus, K.R., Liesegang, T.J., Osato, M.S., Jones, D.B., (1994) Cumitech 13A, Laboratory diagnosis of ocular infections, pp. 9-20. , Washington, DC: American Society for Microbiology; Southwick, F.S., Eye, ear, nose, and throat infections (2014) Infectious diseases a clinical short course, pp. 125-132. , Southwick F., (ed), 3rd edn., New York: McGraw-Hill Education; Schaefer, F., Bruttin, O., Zografos, L., Guex-Crosier, Y., Bacterial keratitis: a prospective clinical and microbiological study (2001) Br J Ophthalmol, 85, pp. 842-847; Cheung, R.P.F., Dipiro, J.T., Vancomycin: an update (1986) Pharmacotherapy, 6, pp. 153-169; Mohammed Fayaz, A., Girilal, M., Mahdy, S.A., Vancomycin bound biogenic gold nanoparticles: a different perspective for development of anti VRSA agents (2011) Process Biochem, 46, pp. 636-641; Moffat, A.C., Osselton, M.D., Widdop, B., (2005) Clarke's analysis of drugs and poisons, , London, UK: Pharmaceutical Press; Vila, M.M.D.C., Oliveira, R.M.D., Gon�alves, M.M., Tubino, M., Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals (2007) Quim Nov, 30, pp. 395-399; Gavini, E., Chetoni, P., Cossu, M., PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies (2004) Eur J Pharm Biopharm, 57, pp. 207-212; Hachicha, W., Kodjikian, L., Fessi, H., Preparation of vancomycin microparticles: importance of preparation parameters (2006) Int J Pharm, 324, pp. 176-184; Ara�jo, J., Gonzalez, E., Egea, M.A., Nanomedicines for ocular NSAIDs: safety on drug delivery (2009) Nanomedicine, 5, pp. 394-401; Kaur, I.P., Garg, A., Singla, A.K., Aggarwal, D., Vesicular systems in ocular drug delivery: an overview (2004) Int J Pharm, 269, pp. 1-14; Liu, G.Y., Omri, A., Sande, L., (2011), http://www.google.com/patents/WO2012149116A2?cl=en; Attama, A., Reichl, S., M�ller-Goymann, C.C., Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct (2008) Int J Pharm, 355, pp. 307-313; Ghadiri, M., Fatemi, S., Vatanara, A., Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size (2012) Int J Pharm, 424, pp. 128-137; Hansraj, G.P., Singh, S.K., Kumar, P., Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential (2015) Int J Biol Macromol, 81, pp. 467-476; Shah, B., Khunt, D., Bhatt, H., Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters (2015) Eur J Pharm Sci, 78, pp. 54-66; Jeong, Y.-I., Na, H.-S., Seo, D.-H., Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity (2008) Int J Pharm, 352, pp. 317-323; Wissing, S.A., Kayser, O., M�ller, R.H., Solid lipid nanoparticles for parenteral drug delivery (2004) Adv Drug Deliv Rev, 56, pp. 1257-1272; Nabi-meibodi, M., Vatanara, A., Rouholamini, A., The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method (2013) Colloids Surf B Biointerfaces, 112, pp. 408-414; Performance standards for antimicrobial susceptibility testing (2009) 19th Informational Suppl CLSI Doc M100-S19. Wayne, PA: CLSI;; Ismail, M.M., Essam, T.M., Mohamed, A.F., Mourad, F.E., Screening for the antimicrobial activities of alcoholic and aqueous extracts of some common species in Egypt (2012) Int J Microbiol Res, 3, pp. 200-207; Performance standards for antimicrobial susceptibility testing (2011) 21st Informational Suppl CLSI Doc M100-S21. Wayne, PA: CLSI;; Hou, D., Xie, C., Huang, K., Zhu, C., The production and characteristics of solid lipid nanoparticles (SLNs) (2003) Biomaterials, 24, pp. 1781-1785; Aksoy, D.Y., Tanriover, M.D., Unal, S., Antimicrobial resistance: preventable or inevitable (2008) Antibiotic policies: fighting resistance, pp. 113-134. , Gould I.M., Meer J.W.V.D., (eds), New York: Springer Science + Business Media, LLC; Aksungur, P., Demirbilek, M., Denkbas, E.B., Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies (2011) J Control Release, 151, pp. 286-294; Mehnert, W., Mader, K., Solid lipid nanoparticles: production, characterization and applications (2001) Adv Drug Deliv Rev, 47, pp. 165-196; Westesen, K., Michel, H.J., Crystallization tendency and polymorphic transitions in triglyceride nanoparticles (1996) Int J Pharm, 129, pp. 159-173; Abdelbary, G., Fahmy, R.H., Diazepam-loaded solid lipid nanoparticles: design and characterization (2009) AAPS PharmSciTech, 10, pp. 211-219; Manosroi, A., Wongtrakul, P., Manosroi, J., Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol (2003) Colloids Surf B Biointerfaces, 30, pp. 129-138; Chibowski, S., Paszkiewicz, M., Krupa, M., Investigation of the influence of the polyvinyl alcohol adsorption on the electrical properties of Al2O3 � solution interface, thickness of the adsorption layers of PVA (2000) Powder Technol, 107, pp. 251-255; Mobarak, D.H., Salah, S., Elkheshen, S.A., Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables (2013) Pharm Dev Technol, 19, pp. 891-900; M�ller, R.H., Vuleta, G.M., Kov?, A.B., Keck, C.M., Physicochemical and engineering aspects solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation (2014) Colloids Surf A Physicochem Eng Asp, 444, pp. 15-25; Uner, M., Yener, G., Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives (2007) Int J Nanomedicine, 2, pp. 289-300; Guinedi, A.S., Mortada, N.D., Mansour, S., Hathout, R.M., Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide (2005) Int J Pharm, 306, pp. 71-82; Jenning, V., Gohla, S., Comparison of wax and glyceride solid lipid nanoparticles (SLN) (2000) Int J Pharm, 196, pp. 219-222; M�ller, R.H., M�der, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery � a review of the state of the art (2000) Eur J Pharm Biopharm, 50, pp. 161-177; Moosa, R.M., Choonara, Y.E., Toit, L.C.D., In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model (2014) Int J Pharm, 466, pp. 296-306; Zakeri-milani, P., Loveymi, B.D., Jelvehgari, M., The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system (2013) Colloids Surf B Biointerfaces, 103, pp. 174-181; Vitorino, C., Carvalho, F.A., Almeida, A.J., Sousa, J.J., The size of solid lipid nanoparticles: an interpretation from experimental design (2011) Colloids Surf B Biointerfaces, 84, pp. 117-130; Gupta, H., Pharm, B., Pharm, M., Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery (2010) Nanomedicine, 6, pp. 324-333 |
|